Immatics Biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Immatics Biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2
Immatics Biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Immatics Biotechnologies GmbH (Immatics) is a clinical stage biopharmaceutical company that develops drugs for the treatment of cancer. It develops peptide based active immunotherapy drug candidates based on it novel technology, XPRESIDENT discovery platform. The company has active programs in several tumor types including gastric cancer, non-small-cell lung cancer and prostate cancer. Its major drug candidates include IMA101, IMA201, IMA202, IMA203, and IMA300/301 which are focused on the development of three ACT approaches ACTolog, ACTengine, and ACTallo to treat cancer. The company has collaborations with Roche, UTHealth and MorphoSys for the advancement of its drug candidates. Immatics is headquartered in Tuebingen, Germany. Immatics Biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. 3
- Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH132859D Number of Pages : 21 Report Format : PDF Publisher Information : 4
5
Table Of Contents for Immatics Biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-05-2017] Table of Contents Table of Contents 2List of Tables 3List of Figures 4Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deal Details 10Venture Financing 10immatics biotech Raises Additional USD29.8 Million in Second Tranche of Series D Financing 10Partnerships 11MorphoSys Enters into Agreement with Immatics Biotech 11immatics Enters Into R&D Agreement With Roche For Cancer Vaccine 12Licensing Agreements 13Amgen Enters into Licensing Agreement with Immatics Biotech 13Immatics Biotech Enters into Licensing Agreement with Sanquin Blood Supply Foundation 14Immatics Biotech, Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement 14Equity Offering 15Immatics US Raises USD10 Million in Financing 15Immatics Biotechnologies GmbH - Key Competitors 17Key Employees 18Locations And Subsidiaries 19Head Office 19Other Locations & Subsidiaries 19Recent Developments 20Corporate Communications 20Jan 08, 2016: Immatics Appoints Katina Dorton as Chief Financial Officer 20Appendix 21Methodology 21About GlobalData 21Contact Us 21Disclaimer 21 6
List Of Tables in Immatics Biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-05-2017] List of Tables Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Key Facts 1 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7 Immatics Biotechnologies GmbH, Deals By Therapy Area, 2011 to YTD 2017 8 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9 immatics biotech Raises Additional USD29.8 Million in Second Tranche of Series D Financing 10 MorphoSys Enters into Agreement with Immatics Biotech 11 immatics Enters Into R&D Agreement With Roche For Cancer Vaccine 12 Amgen Enters into Licensing Agreement with Immatics Biotech 13 Immatics Biotech Enters into Licensing Agreement with Sanquin Blood Supply Foundation 14 Immatics Biotech, Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement 14 Immatics US Raises USD10 Million in Financing 15 Immatics Biotechnologies GmbH, Key Competitors 17 Immatics Biotechnologies GmbH, Key Employees 18 Immatics Biotechnologies GmbH, Other Locations 19 7
List Of Figures, Charts and Diagrams in Immatics Biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-0- -2017] List of Figures Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7 Immatics Biotechnologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8 8
How to Buy... Immatics Biotechnologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-05-2017] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9